PT Mitra Keluarga Karyasehat Tbk (MIKA) recorded positive performance throughout 2020. The listed company with the issuer code MIKA recorded growth both from the top line and bottom line.

Based on its financial report, MIKA's net income increased by 6.69% year on year (YoY) to Rp3.42 trillion. At the end of 2019, MIKA posted revenue at Rp3.21 trillion.

Most of the income comes from hospitalization. Inpatient care contributed up to Rp2.24 trillion to the total income.

This figure has increased by 13.42% from 2019 of Rp1.98 trillion. Meanwhile, income from drugs and medical equipment still contributed the most to hospitalizations, up to Rp1.02 trillion.

Meanwhile, throughout 2020 outpatient income reached Rp1.18 trillion of MIKA's total revenue. MIKA recorded outpatient care contribution to have increased compared to 2019, which was only Rp1.23 trillion.

DKI Jakarta and West Java still dominate MIKA's revenue from regions, which rose to Rp2.74 trillion. However, hospital revenue from the Tegal and Surabaya segments increased significantly by 20.87% YoY to Rp679.11 billion.

Revenue from the DKI Jakarta and West Java regions has increased by 3.67% YoY. The increase in terms of net income raised MIKA's net profit for the year to double digits.

Throughout 2020 MIKA pocketed Rp923.47 billion in net profit, an increase of 16.69% compared to 2019, which amounted to Rp791.42 billion.

As of the end of 2020, MIKA has total assets of Rp6.37 trillion, rising 14.28% compared to 2019,  at Rp5.58 trillion. Its liabilities increased by 9.16% to Rp855.19 billion, and its equity increased 15.12% to Rp5.52 trillion.